Clinical Study

Methotrexate Associated Renal Impairment Is Related to Delayed Elimination of High-Dose Methotrexate

Table 3

The predictive value of S-creatinine, S-creatinine ratio, and CCR for delayed MTX elimination.

ParametersAUC valueCut-offSensitivitySpecificity

S-creatinine 24 h0.756 (0.672–0.840)<0.001>35.068.6%70.1%
S-creatinine ratio 24 h0.759 (0.668–0.850)<0.001>1.12969.8%80.0%
CCR_24 h 0.771 (0.688–0.854)<0.001<100.068.6%74.1%
CCR ratio 24 h 0.728 (0.626–0.829)<0.001<0.82467.4%73.1%
S-creatinine 0 h 0.422 (0.324–0.519)0.130
CCR_0 h0.509 (0.409–0.608)0.859

S-creatinine 24 h: serum creatinine level in 24 hours after MTX infusion; S-creatinine ratio 24 h: the ratio of serum creatinine level in 24 hours to creatinine level before MTX infusion; CCR_24 h: creatinine clearance rate in 24 hours after MTX infusion; CCR ratio 24 h: the ratio of CCR in 24 hours to CCR before MTX infusion; S-creatinine 0 h: serum creatinine level before MTX infusion; CCR_0 h: creatinine clearance rate before MTX infusion.